Large gap with delayed quotes
|
Last quote
04/25/2026
-
02:00:00
|
Bid
04/27/2026 -
14:56:33
|
Bid Volume |
Ask
04/27/2026 -
14:56:33
|
Ask Volume |
|---|---|---|---|---|
|
12.35
+0.20
(
+1.65% )
|
10.47
|
100 |
15.94
|
200 |
Analysis date: 24.04.2026
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 21.04.2026.
Interest
Very weak
Very weak
One star since 21.04.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 17.04.2026 at a price of 12.71.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 14.04.2026.
4wk Rel Perf
-3.91%
-3.91%
The four-week dividend-adjusted underperformance versus SP500 is 3.91%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 03.03.2026.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.28%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.46%.
Mkt Cap in $bn
0.50
0.50
With a market capitalization <$2bn, ORTHOFIX MEDICAL is considered a small-cap stock.
G/PE Ratio
1.76
1.76
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
-14.09
-14.09
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
24.86%
24.86%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
148
148
For 1% of index variation, the stock varies on average by 1.48%.
Correlation
0.51
0.51
50.91% of stock movements are explained by index variations.
Value at Risk
3.89
3.89
The value at risk is estimated at USD 3.89. The risk is therefore 31.53%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
11.07.2008
11.07.2008